The incidence of myelodysplastic syndromes (MDS) increases with age. Older patients with MDS have a poor prognosis, further influenced by individual factors such as comorbidity, functional status and cognitive status . Currently, patient's performance status is assessed using criteria outlined by Eastern Cooperative Oncology Group (ECOG). An ECOG score of 0–2 is considered ‘fit’, while a score of 3 is considered ‘vulnerable’. Routine hematology assessment does not routinely identify all geriatric related health issues and hence a comprehensive geriatric assessment (CGA) is recommended to detect vulnerability to adverse outcomes in older patients with cancer .
- Myelodysplastic syndromes